The added value of pharmacogenomics to prescribing
Raliat Onatade, Chief Pharmacist for North Thames Genomic Medicines Service Alliance, recently gave the opening keynote address at the EAHP Congress in Lisbon (March 2023) on the subject… read more.
Raliat Onatade, Chief Pharmacist for North Thames Genomic Medicines Service Alliance, recently gave the opening keynote address at the EAHP Congress in Lisbon (March 2023) on the subject… read more.
Effective communication among healthcare professionals is essential for ensuring safe medical care. Assertiveness, the ability to express oneself candidly while respecting others, is seen as a crucial factor… read more.
Growing evidence supports prescribing psychostimulant medications to help reduce use of illegal stimulants such as methamphetamine, authors write in a CMAJ (Canadian Medical Association Journal) commentaryhttps://www.cmaj.ca/lookup/doi/10.1503/cmaj.230266. Illegal stimulant use is… read more.
The new discipline aims to address sustainability gaps in the entire life-cycle of medicines, from drug discovery to end-of-life, and reduce the environmental footprint of pharmaceuticals. The University… read more.
A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30… read more.
The management of heart failure treatment is probably best done by a primary care team and pharmacists can play a major role in prescribing, says Paul Forsyth, Lead… read more.
The key challenges in heart failure treatment include reaching the target dose, awareness of drug-specific issues that influence effectiveness and tackling adherence problems, according to Paul Forsyth, Lead… read more.
Current thinking advocates the use of ‘four pillars of heart failure therapy’. Paul Forsyth, Lead Pharmacist, Clinical Cardiology at NHS Greater Glasgow and Clyde, explains how this treatment… read more.
A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30… read more.
New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that community mental health patients who were prescribed antidepressants were… read more.
An investigator with the University of Kansas School of Pharmacy has filed an invention disclosure, part of a provisional patent application with the United States Patent and Trademark… read more.
Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 times as likely to prescribe mineralocorticoid receptor antagonists (MRAs), a guideline-recommended class of heart… read more.